Board approves revised FY26 results, adds cash flow statement
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved revised consolidated financial results for FY ended March 31, 2026. The revision only added the Consolidated Statement of Cash Flows after BSE flagged non-submission and levied a fine. No change to actual financial numbers. FY26 revenue from operations stood at Rs 1,334.75 lakhs with a net loss of Rs 221.41 lakhs and EPS of minus Rs 3.69. Q4 revenue was Rs 196.65 lakhs versus Rs 146.81 lakhs in Q3. Operating cash flow was positive at Rs 63.83 lakhs. Auditors issued an unmodified opinion with an emphasis of matter note on the revision. This is the first year of consolidation after subsidiary Mikusu Global Industries was incorporated in August 2025.
No change in financial numbers; revision only adds the missing cash flow statement. Company still loss-making at consolidated level with weak margins.